Claim
Strong Support
mechanistic
Analysis v3

After bilio-pancreatic bypass surgery in severely obese adults, levels of the active thyroid hormone FT3 drop by 10.5% within three months and stay 11.2% lower for up to three and a half years, even...

31
Pro
0
Against

Mechanism

Synthesis from 1 study

How it works

After surgery that stops fat from being digested, the body can't make enough active thyroid hormone because it lacks the fats needed for the conversion process. This low level of active hormone stays low for years, even after weight loss stops, because the problem is not weight — it's the lack of...

Most probable mechanism

In Simple Terms

After surgery that prevents proper fat digestion, the body lacks the fats needed to activate enzymes that convert thyroid hormone into its active form. This causes a lasting drop in active thyroid hormone, even after weight stops changing.

Causal chain
1

Bilio-pancreatic bypass diverts bile and pancreatic enzymes away from the duodenum, preventing emulsification and digestion of dietary fats.

Verified by multiple studies
which leads to
2

Reduced fat absorption limits the availability of fatty acids and cholesterol, which are required cofactors for deiodinase type 1 enzyme activity in the liver and kidneys.

Verified by multiple studies
which leads to
3

Deiodinase type 1 activity decreases, reducing the conversion of thyroxine (T4) into the biologically active triiodothyronine (T3).

Verified by multiple studies
which leads to
4

Circulating free triiodothyronine (FT3) levels fall and remain suppressed long-term, even after body weight and composition stabilize.

Verified by multiple studies

Less supported by current evidence, but not ruled out

In Simple Terms

When the body burns more protein for energy after surgery, it sends signals that adjust the pituitary gland's target level for thyroid hormone, keeping TSH normal even when active thyroid hormone is low.

Causal chain
1

Post-surgical nutrient restriction shifts energy metabolism toward increased protein breakdown and oxidation.

Supported by evidence
which leads to
2

Elevated amino acid catabolism generates metabolic signals that alter hypothalamic TRH release or pituitary thyrotroph sensitivity.

Supported by evidence
which leads to
3

The pituitary gland maintains normal TSH secretion despite low FT3 and normal FT4, indicating a recalibrated set point for thyroid hormone regulation based on substrate availability.

Supported by evidence

Evidence from Studies

Supporting (1)

31

Community contributions welcome

Contradicting (0)

0

Community contributions welcome

No contradicting evidence found

Gold Standard Evidence Needed

According to GRADE and EBM methodology, here is what ideal scientific evidence would look like to definitively prove or disprove this specific claim, ordered from strongest to weakest evidence.

Sign up to see full verdict